# A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)

> **NCT00750334** · PHASE1 · TERMINATED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 2 (actual)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DRUG:** clofarabine
- **DRUG:** clofarabine

## Key facts

- **NCT ID:** NCT00750334
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Terminated to focus on comparable trial, CLOMDS02507
- **Last updated:** 2015-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00750334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00750334, "A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00750334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*